Fingerprint
Dive into the research topics of 'Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): A randomised, double-blind, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically